Since the beginning
of history, natural products have been an abundant
source of bioactive molecules for the treatment of different diseases,
including cancer. Many allyl derivatives, which have shown anticancer
activity both
in vitro
and
in vivo
in a large number of cancers, are bioactive molecules found in garlic,
cinnamon, nutmeg, or mustard. In addition, synthetic products containing
allyl fragments have been developed showing potent anticancer properties.
Of particular note is the allyl derivative 17-AAG, which has been
evaluated in Phase I and Phase II/III clinical trials for the treatment
of multiple myeloma, metastatic melanoma, renal cancer, and breast
cancer. In this Perspective, we compile extensive literature evidence
with descriptions and discussions of the most recent advances in different
natural and synthetic allyl derivatives that could generate cancer
drug candidates in the near future.